City

Guangzhou (2)

Condition

Local Advanced High Risk Nasopharyngeal Carcinoma (2)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

Sponsor

Sun Yat-sen University (1)

Zhao Chong (1)

Collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)

Jiangxi Provincial Cancer Hospital (1)

National Cancer Centre, Singapore (1)

Intervention

imrt combine with cisplatin concurrent chemotherapy (2)

imrt combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

local advanced high risk nasopharyngeal carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine

Recruiting

Local Advanced High Risk Nasopharyngeal Carcinoma

IMRT combine with cisplatin concurrent chemotherapy
IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy

Guangzhou, Guangdong, China

Cancer Center, Sun Yat-sen University

Apr 9, 2022

Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine

Active, not recruiting

Local Advanced High Risk Nasopharyngeal Carcinoma

IMRT combine with cisplatin concurrent chemotherapy
IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy

Guangzhou, Guangdong, China

Cancer Center, Sun Yat-sen University

Mar 13, 2022